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Background: Size and shape of the treatment zone after Irreversible electroporation (IRE) can be difficult to depict
due to the use of multiple applicators with complex spatial configuration. Exact geometrical definition of the
treatment zone, however, is mandatory for acute treatment control since incomplete tumor coverage results in
limited oncological outcome. In this study, the “Chebyshev Center Concept” was introduced for CT 3d rendering to
assess size and position of the maximum treatable tumor at a specific safety margin.
Methods: In seven pig livers, three different IRE protocols were applied to create treatment zones of different size
and shape: Protocol 1 (n = 5 IREs), Protocol 2 (n = 5 IREs), and Protocol 3 (n = 5 IREs). Contrast-enhanced CT was
used to assess the treatment zones. Technique A consisted of a semi-automated software prototype for CT 3d
rendering with the “Chebyshev Center Concept” implemented (the “Chebyshev Center” is the center of the largest
inscribed sphere within the treatment zone) with automated definition of parameters for size, shape and position.
Technique B consisted of standard CT 3d analysis with manual definition of the same parameters but position.
Results: For Protocol 1 and 2, short diameter of the treatment zone and diameter of the largest inscribed sphere
within the treatment zone were not significantly different between Technique A and B. For Protocol 3, short
diameter of the treatment zone and diameter of the largest inscribed sphere within the treatment zone were
significantly smaller for Technique A compared with Technique B (41.1 ± 13.1 mm versus 53.8 ± 1.1 mm and 39.0 ±
8.4 mm versus 53.8 ± 1.1 mm; p < 0.05 and p < 0.01). For Protocol 1, 2 and 3, sphericity of the treatment zone was
significantly larger for Technique A compared with B.
Conclusions: Regarding size and shape of the treatment zone after IRE, CT 3d rendering with the “Chebyshev
Center Concept” implemented provides significantly different results compared with standard CT 3d analysis. Since
the latter overestimates the size of the treatment zone, the “Chebyshev Center Concept” could be used for a more
objective acute treatment control.
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Focal tumor ablation is an accepted option for the treat-
ment of primary and secondary malignant liver tumors.
Irreversible electroporation (IRE) was introduced as a
non-thermal technique for tissue destruction. After local
application of high-voltage electrical pulses of microsec-
ond duration, homogeneous areas of non-viable cells are
induced [1]. In first clinical studies, IRE demonstrates
promising results for the treatment of malignant liver le-
sions [2-4]. The routine use of IRE, however, is still not
established [5,6]. Whereas radiofrequency ablation and
microwave ablation induce cell death via thermal dam-
age, the exact mechanisms for IRE are not entirely
understood [7]. Nonetheless, IRE is attributed with po-
tential advantages compared with thermal ablation (e.g.
reduced collateral damage and insignificance of the heat-
sink effect) [5]. Those advantages can be explained with
the relative resistance of low lipid containing structures
(e.g. extracellular matrix and endothelial cells) to the
electrical pulses while high lipid containing structures
(e.g. tumor cells) can be destroyed completely [8,9]. Ac-
cordingly, IRE should be a promising alternative espe-
cially if tumors are located near vulnerable structures.
As with thermal ablation, the treatment zone after IRE
must cover the entire tumor in addition to a safety mar-
gin. As demonstrated by Wang et al., the size of the
safety margin plays a key role for the oncological success
of focal tumor ablation [10]. After radiofrequency abla-
tion of colorectal liver metastases, they found that a
safety margin uniformly larger than 5 mm, defined with
post-interventional contrast-enhanced CT, is associated
with better local tumor control. For the combination of
optimal oncological outcome with liver-sparing tumor
ablation, which is relevant for the minimization of
procedure-related complications, another prerequisite is
mandatory: congruency of tumor center and coagulation
center [11]. Currently, there exists no clinically relevant
software that can be used to determine whether the
treated tumor and the intended safety margin are cov-
ered completely by the treatment zone. Standard CT 3d
analysis of the treatment zone after focal tumor ablation
consists of measurements based on standard CT image
planes (e.g. axial), without meeting the clinical require-
ments of interventional radiologists in terms of objective
treatment control. A major drawback of currently avail-
able 3d software is suboptimal assessment of the exact
geometry of the treatment zone in relation to the tumor
extent. For example indentations limiting the expansion
of the treatment zone need to be assessed since those
are likely to represent the site of incomplete tumor de-
struction and local recurrence. Since IRE can be per-
formed with lots of different protocols (e.g. up to six
applicators with a tip exposure of up to 40 mm) all af-
fecting significantly size and shape of the treatmentzone, the exact geometrical assessment is mandatory to
further improve the procedural success. This issue was
published by Adeyanju et al., who demonstrated that
IRE protocols impact not only the extent of the treat-
ment zone but also the maximum treatable tumor size
[12].
With this background, the objective of our study was
defined: to introduce the “Chebyshev Center Concept”
for CT 3d rendering to assess size and position of the
maximum treatable tumor size at a specific safety mar-
gin after IRE in a pig liver model, and to demonstrate
better performance compared with standard CT 3d ana-
lysis. For our study, the “Chebyshev Center” of the treat-
ment zone is the center of the largest inscribed sphere
within the treatment zone. In geometry, the largest
inscribed sphere is the sphere that bounds the edges of a
three-dimensional body in such a manner that there is
no other sphere that lies completely within that three-
dimensional body and at the same time has a larger
diameter than the largest inscribed sphere. The three-
dimensional body corresponds to the treatment zone,
and the largest inscribed sphere is the largest sphere
that is covered completely by the treatment zone. The
“Chebyshev Center Concept” can be used to quantify and
visualize diameter and position of the largest inscribed
sphere within the treatment zone after focal tumor abla-
tion. This sphere is relevant since it allows the definition
of the maximum treatable tumor size at a specific safety
margin. Furthermore, the “Chebyshev Center Concept” is
applicable to determine whether tumor and intended
safety margin is located within the treatment zone (or in
other words whether the concrete treatment zone is ad-
equate for a specific tumor extent).
Methods
The experiments were performed in accordance with the
“Guide for the Care and Use of Laboratory Animals”.
“State Animal Care and Ethics Committee” approval was
obtained.
Animal preparation
Seven healthy landrace pigs with a body weight between
35 and 41 kg were sedated with an intramuscular cock-
tail consisting of 10 mg ketamine, 6 mg azaperone and
0.4mg midazolam per kg body weight. Peripheral and
central venous catheters were installed. After intubation,
anesthesia was maintained with isoflurane. Intravenous
bolus injections with pancuronium were used to induce
and maintain muscle relaxation. A continuous 4-lead
electrocardiogram was performed throughout the proced-
ure. Before and immediately after IRE, contrast-enhanced
CT was performed with a 128-slice multi-detector row
CT scanner (Somatom Definition Flash; Siemens Medical
Solutions, Forchheim, Germany). The CT protocol
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injection of 70 ml of iodinated contrast material, arterial
(delay of 5 s after reaching the trigger threshold of 100
HU), venous (delay of 50 s) and late (delay of 180 s) phases
followed. Image reconstructions included axial image
planes with a slice thickness of 1 mm and an overlap of
0.5 mm. The CT scan immediately after IRE was intended
as acute treatment control according to best clinical prac-
tice. Animals were sacrificed subsequently.
IRE procedure
IRE was performed with a commercial generator (Nano-
Knife™ Electroporator; AngioDynamics® Inc., Queensbury,
USA). Electrocardiogram synchronization was used to
prevent cardiac arrhythmias. Commercial monopolar 19G
applicators (NanoKnife™ Applicator; AngioDynamics® Inc.,
Queensbury, USA) served for local pulse application. A
total of 15 IREs were carried out. Three different IRE pro-
tocols were used to obtain different extents of the treat-
ment zone: Protocol 1 (three applicators, tip exposure of
20 mm, distance between pairs of applicators of 15 mm,
pulse number of 90, pulse length of 90 μs, and electric
field of 1500 V/cm; n = 5 IREs), Protocol 2 (three applica-
tors, tip exposure of 25 mm, distance between pairs of ap-
plicators of 20 mm, pulse number of 90, pulse length of
90 μs, and electric field of 1500 V/cm; n = 5 IREs), and
Protocol 3 (six applicators, tip exposure of 30 mm, dis-
tance between pairs of applicators of 15 mm, pulse num-
ber of 70, pulse length of 90 μs, and electric field of 1400
V/cm; n = 5 IREs). Based on the information of the manu-
facturer as well as on findings of published and own IRE
experience, those protocols allow predicting the size of the
treatment zone, with treatment zones between 1 and 5
cm. In this context, the different mechanisms of tissue de-
struction between IRE and thermal ablation are important
to mention. In thermal ablation, heat expands from the tip
of an applicator to the periphery, and power output and
ablation time are major predictors for size and shape of
the coagulation zone. On the contrary, size and shape of
the treatment zone after IRE is determined by number
and spatial configuration of applicators, tip exposure,
pulse number, pulse length as well as electric field. The
treatment zones expand between the different pairs of ap-
plicators, resulting finally in one overlapping treatment
zone. According to our treatment plan, applicators were
positioned standardized across all animals. In one pig, two
IREs according to Protocol 1 were performed in the right
liver and one IRE according to Protocol 2 was performed
in the left liver. In another pig, one IRE according to
Protocol 1 was performed in the left liver and one IRE ac-
cording to Protocol 2 was performed in the right liver. In
two other pigs, one IRE according to Protocol 1 was per-
formed in the left liver and one IRE according to Protocol
3 was performed in the right liver. In the three remainingpigs, one IRE according to Protocol 2 was performed in
the left liver and one IRE according to Protocol 3 was per-
formed in the right liver. Consequently, in six pigs a max-
imum of 2 IREs per pig was realized, and in one pig a
maximum of three IREs was realized. This proceeding
avoided overlap and interaction between the IREs in the
same liver (e.g. impact of microvascularization resulting in
inaccurate CT enhancement patterns after application of
intravenous contrast material). All applicators were posi-
tioned step-by-step in parallel fashion under CT guidance.
The correct applicator configuration according to the treat-
ment plan was confirmed with a non-enhanced CT scan
using multi-planar image planes.
Analysis of size and shape of the treatment zone
The image data were extracted from our institutional
prospective digital database (GE Centricity 4.1, GE
Healthcare, Barrington, USA) and analyzed on a PC ap-
plying the software described in this study. Two tech-
niques for the analysis of the treatment zone were
compared: Technique A versus Technique B (not to be
confused with the different IRE Protocols) (Figure 1). Ac-
cording to other publications, the treatment zone after
IRE was defined as the hypodense area with sharp demar-
cation on contrast-enhanced CT images of the venous
phase [13,14].
Technique A
Technique A consisted of a semi-automated software
prototype for CT 3d rendering with the “Chebyshev
Center Concept” implemented (MITK freeware “Geomet-
ric evaluation of ablations” http://www.mitk.org/Abla
tionEvaluation; German Cancer Research Center (dkfz)
Heidelberg, Heidelberg, Germany). Axial image planes
with a slice thickness of 1 mm and an overlap of 0.5 mm
were uploaded (Figure 2). Treatment zones were outlined
manually by means of cursor in the sense of segmentation.
After segmentation, parameters for size and shape (long,
intermediate and short diameter, circularity and sphericity
as well as the diameter of the largest inscribed sphere
within the treatment zone and the diameter of the largest
possible treatable tumor sphere for both applying the
“Chebyshev Center”) were obtained automatically. The
geometrical center of the treatment zone (from now
on the barycenter) was determined automatically by
using a principal component analysis. The diameter of
the treatment zone through the barycenter in direction
of the eigenvector with the largest principal component
was defined as the long diameter. The diameter of the
treatment zone perpendicular to the long diameter and
through the barycenter in direction of the second largest
principal component eigenvector was defined as the
intermediate diameter. The third diameter of the treat-
ment zone perpendicular to the long and intermediate
Figure 1 Flowchart for illustration of the analysis of the treatment zone.
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short diameter. Consequently, the barycenter is the inter-
section point of long, intermediate and short diameter of
the treatment zone. Circularity and sphericity of the
treatment zone are measures to describe the shape of the
treatment zone applying long, intermediate and/or short
diameter [15-17]:
(1) Circularity of the treatment zone = short diameter/
long diameter (a number of “1” indicates a perfect round-
ness) and
(2) Sphericity of the treatment zone = long diameter/
((intermediate diameter + short diameter)/2) (a number
of “1” indicates a perfect roundness).
The largest inscribed sphere within the treatment zone
was defined automatically. As mentioned above, the
“Chebyshev Center” is the center of this sphere, and
can be applied for the determination of diameter and
position (barycenter offset) of the largest inscribed
sphere within the treatment zone. Thereby, the barycen-
ter offset is the distance between the barycenter and the
“Chebyshev Center”. The diameter of the largest possible
treatable tumor sphere was defined automatically also.
This sphere has the same center as the largest inscribed
sphere within the treatment zone (“Chebyshev Center”).
Moreover, the largest possible treatable tumor sphere
has a diameter 10 mm smaller as the short diameter
(corresponding to a uniform safety margin of 5 mm).Technique B
Technique B consisted of standard CT 3d analysis with-
out specific software assistance (such as principal compo-
nent analysis). Axial image planes with a slice thickness
of 1 mm and an overlap of 0.5 mm were uploaded in the
“CTA Abdomen” workflow on a commercial work station
(TeraRecon, INC., Aquarius, iNtuition™ Edition, Ver.
4.4.4.23.771, San Mateo, USA) (Figure 3). Applying the
multi-planar mode, the absolute longest diameter of the
treatment zone was measured manually on axial image
planes. Perpendicular to this diameter, the longest diam-
eter of the treatment zone was measured manually on
axial image planes. On coronal image planes, the longest
craniocaudal diameter of the treatment zone was mea-
sured manually. This proceeding is in line with current
clinical practice for treatment control after radiofrequency
ablation [15-17]. The three measured diameters were or-
dered by size, and defined as long, intermediate and short
diameter of the treatment zone. Circularity and sphericity
of the treatment zone were calculated according to equa-
tions (1) and (2). The diameter of the largest inscribed
sphere within the treatment zone was defined equal to the
short diameter. The diameter of the largest possible treat-
able tumor sphere was defined using a diameter 10 mm
smaller as the diameter of the largest inscribed sphere
within the treatment zone. For Technique B, the barycen-
ter offset was not assessable.
Figure 2 Technique A (Semi-automated Software Prototype for CT 3d Rendering with the “Chebyshev Center Concept” implemented) -
User Interface. The MITK user interface consists of three work columns: “data manager” in the left column, “display” in the middle column, and
post-processing tools (“Segmentation” and “Lesion Tools” in this case) in the right column. Images in different formats (e.g. DICOM or JPEG) can
be uploaded and scrolled in the “data manager” column. Multi-planar image planes are visualized in the “display” column. In the post-processing
tool column, the treatment zone can be outlined manually by means of cursor (in the sense of a segmentation) applying “Segmentation”. Then,
applying “Lesion Tools”, long, intermediate and short diameter, circularity and sphericity as well as the diameter of the largest inscribed sphere
within the treatment zone and the diameter of the largest possible treatable tumor sphere at a defined safety margin (in this case 5mm) inclusive
of the barycenter offset can be calculated automatically.
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To quantify the differences between Technique A and
Technique B regarding the largest inscribed sphere within
the treatment zone, the difference ratio was calculated:
(3) Difference ratio = Diameter of the largest inscribed
sphere within the treatment zoneTechnique A - Diameter
of the largest inscribed sphere within the treatment
zoneTechnique B.
The difference ratio indicates the absolute difference be-
tween Technique A and Technique B. A negative differ-
ence ratio means that the parameter for Technique A is
smaller than for Technique B (or in other words that
standard CT 3d analysis overestimates the extent of the
treatment zone), whereas a positive difference ratio means
that the parameter for Technique A is larger than for
Technique B (or in other words that standard CT 3d ana-
lysis underestimates the extent of the treatment zone).
Statistics
Prism software (Version 6.00, GraphPad Software, LaJolla,
USA) was used. Quantitative data were presented asmean ± standard deviation, and range. To evaluate statis-
tical differences between Technique A and Technique B,
the Wilcoxon signed-rank test was used. To describe stat-
istical differences between IRE Protocol 1, Protocol 2 and
Protocol 3, the Kruskal-Wallis test was applied. P < 0.05
was defined as the level of significance.
Results and discussion
The mean duration of the IRE procedures per pig was
37 ± 12 min (25-70 min).
Size of the treatment zone
Detailed data are presented in Table 1 (Figures 4, 5 and
6). For Protocol 1 and Protocol 2, long, intermediate and
short diameters were not significantly different be-
tween Technique A and Technique B, respectively.
There was a trend for a larger long diameter for Tech-
nique A for Protocol 1 as well as a trend for smaller
short diameter for Technique A for Protocol 1 and
Protocol 2, respectively. For Protocol 3, long and inter-
mediate diameters were not significantly different
Figure 3 Technique B (Standard CT 3d Analysis) - User Interface. This user interface is clinically established, and provides the possibility to
measure manually diameters on axial, coronal and sagittal image planes (CTA abdomen workflow, multi-planar mode).
Table 1 Size of the treatment zone
Long diameter (mm) Intermediate diameter (mm) Short diameter (mm)
Technique A1 Technique B2 Technique A1 Technique B2 Technique A1 Technique B2
Protocol 13 42.1 ± 3.2#,* 37.5 ± 10.2#,** 30.1 ± 3.2+,*** 27.9 ± 5.5+,**** 17.2 ± 6.0°,***** 19.9 ± 4.6°,******
(39.3 - 47.2) (29.4 - 48.6) (26.6 - 33.7) (22.0 - 32.7) (10.9 - 24.4) (15.4 - 26.4)
Protocol 24 43.7 ± 8.6##,* 43.8 ± 3.9##,** 35.7 ± 8.2++,*** 37.1 ± 6.2++,**** 27.9 ± 4.2°°,***** 31.1 ± 10.5°°,******
(30.4 – 52.8) (40.1 - 50.2) (26.1 – 44.8) (30.6 - 46.0) (25.3 - 35.3) (17.5 - 42.1)
Protocol 35 74.5 ± 6.1###,* 71.0 ± 3.4###,** 56.3 ± 5.3+++,*** 56.3 ± 2.9+++,**** 41.1 ± 13.1°°°,***** 53.8 ± 1.1°°°,******
(63.7 - 78.1) (67.3 - 75.1) (47.2 - 60.1) (52.7 - 59.2) (20.7 - 52.6) (52.4 - 54.9)
1semi-automated software prototype for CT 3d rendering with the “Chebyshev Center Concept” implemented;
2standard CT 3d analysis;
3Protocol 1 with n = 5 IREs (three applicators, tip exposure of 20 mm, distance between pairs of applicators of 15 mm, pulse number of 90, pulse length of 90 μs,
and electric field of 1500 V/cm);
4Protocol 2 with n = 5 IREs (three applicators, tip exposure of 25 mm, distance between pairs of applicators of 20 mm, pulse number of 90, pulse length of 90 μs,
and electric field of 1500 V/cm);
5Protocol 3 with n = 5 IREs (six applicators, tip exposure of 30 mm, distance between pairs of applicators of 15 mm, pulse number of 70, pulse length of 90 μs,
and electric field of 1400 V/cm);
statistical differences between Technique A and Technique B were analyzed with the Wilcoxon signed-rank test: #p > 0.05; ##p > 0.05; ###p > 0.05; +p > 0.05;
++p > 0.05; +++p > 0.05; °p > 0.05; °°p > 0.05; °°°p < 0.05;
statistical differences between Protocol 1, Protocol 2 and Protocol 3 were analyzed with the non-parametric Kruskal-Wallis test: *p < 0.01; **p < 0.01; ***p < 0.01;
****p < 0.005; *****p < 0.01; ******p < 0.005.
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Figure 4 Technique A (Semi-automated Software Prototype for CT 3d Rendering with the “Chebyshev Center Concept” implemented) -
Image Example. A-D Axial image plane (A) and sagittal image plane (B) as well as corresponding volume rendering (C, D) – IRE Protocol 2. E-H
Axial image plane (E) and coronal image plane (F) as well as corresponding volume rendering (G, H) – IRE Protocol 3. Note: after manual
segmentation of the treatment zone (green), long, intermediate and short diameter (LCD, ICD and SCD) as well as the largest inscribed sphere
within the treatment zone (yellow) and the largest possible treatable tumor sphere (black) were defined automatically (in Figure 4E, SCD is not
indicated since its craniocaudal course). The barycenter offset is the distance between the barycenter of the treatment zone (intersection point of
long, intermediate and short diameter) and the “Chebyshev Center” (center of the largest inscribed sphere within the treatment zone = center of
the largest possible treatable tumor sphere). Observe the conspicuous eccentricity of the “Chebyshev Center” within the treatment zone (which is
quantified by the barycenter offset) on standard image planes (B and E) which is not assessable with standard CT 3d analysis (Figure 5).
Visualization and quantification of size and position of the largest inscribed sphere within the treatment zone (as well as of the largest possible
treatable tumor sphere) can be relevant for acute treatment control after IRE (e.g. confirmation of the intended safety margin size).
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There was a trend for a larger long diameter for Tech-
nique A for Protocol 3. For Protocol 3, the short diameter
was significantly smaller for Technique A comparedwith Technique B (41.1 ± 13.1 mm versus 53.8 ± 1.1 mm;
p < 0.05). All parameters for Technique A and Technique
B were significantly different between Protocol 1, Protocol
2 and Protocol 3, respectively.
Figure 5 Technique B (Standard CT 3d Analysis) - Image Example. A, B axial image plane (A) as well as coronal image plane (B) – IRE
Protocol 1. Note: in the axial image plane, the absolute longest diameter of the treatment zone was measured, and perpendicular to this
parameter, the longest diameter of the treatment zone was determined. In the coronal image plane, the longest craniocaudal diameter of the
treatment zone was determined. These three diameters were ordered by size and defined as long, intermediate and short diameter. The diameter
of the largest inscribed sphere within the treatment zone was defined equal to the short diameter. The barycenter offset is not assessable
applying this approach.
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Detailed data are presented in Table 2 (Figures 4, 5 and
6). For Protocol 1 and Protocol 2, circularity was not sig-
nificantly different between Technique A and Technique
B, respectively. Sphericity was significantly larger for Tech-
nique A compared with Technique B for Protocol 1 and
Protocol 2, respectively (1.7 ± 0.3 versus 1.0 ± 0.2 and 1.4 ±
0.2 versus 0.9 ± 0.1; p < 0.01 and p < 0.01, respectively). For
Protocol 3, circularity and sphericity were significantly dif-
ferent between Technique A and Technique B, respectively
(0.5 ± 0.2 versus 0.8 ± 0.1 and 1.6 ± 0.2 versus 0.9 ± 0.1; p <
0.01 and p < 0.01, respectively). Circularity and sphericity
for Technique A and Technique B were not significantly
different between Protocol 1, Protocol 2 and Protocol 3,
respectively.
Diameter and position of the largest inscribed sphere
within the treatment zone
Detailed data are presented in Table 3 (Figures 4 and 6).
For Protocol 1 and Protocol 2, the diameter of the lar-
gest inscribed sphere within the treatment zone as well
as the diameter of the largest possible treatable tumor
sphere were not significantly different between Tech-
nique A and Technique B, respectively. There was a
trend for a smaller diameter of the largest inscribed
sphere within the treatment zone as well as a trend for a
smaller diameter of the largest possible treatable tumor
sphere for Technique A for Protocol 2, respectively. For
Protocol 3, the diameter of the largest inscribed sphere
within the treatment zone as well as the diameter of
the largest possible treatable tumor sphere were signifi-
cantly different between Technique A and Technique B,
respectively (39.0 ± 8.4 mm versus 53.8 ± 1.1 mm and
29.0 ± 8.4 mm versus 43.8 ± 1.1 mm; p < 0.01 and p < 0.01,
respectively). The barycenter offset was not assessable forTechnique B. All parameters but the barycenter offset
for Technique A and Technique B were significantly dif-
ferent between Protocol 1, Protocol 2 and Protocol 3,
respectively.
Differences between technique A and technique B
For Protocol 1, Protocol 2 and Protocol 3, the difference
ratio was negative (-0.4 ± 1.5 mm (-1.8-1.2 mm), -6.4 ± 8.7
mm (-16.3-5.1 mm) and -14.9 ± 7.4 mm (-25.6–7.9 mm),
respectively). Thereby, significant differences existed be-
tween Protocol 1, Protocol 2 and Protocol 3 (p < 0.05).
Discussion
In this in-vivo pig liver study, significant differences re-
garding the geometry of the treatment zone after IRE
exist when CT 3d rendering with the “Chebyshev Center
Concept” implemented (Technique A) is compared with
standard CT 3d analysis (Technique B). In summary, the
diameter of the largest inscribed sphere within the treat-
ment zone and the diameter of the largest possible treat-
able tumor sphere either were identical (for IRE Protocol
1), tended to be smaller (for IRE Protocol 2), or were sig-
nificantly smaller (for IRE Protocol 3) for Technique A
compared with Technique B. For all IRE protocols, spher-
icity was significantly larger for Technique A compared
with Technique B indicating rounder treatment zones for
the latter. On contrary to Technique B, the position of the
largest inscribed sphere within the treatment zone as well
as the position of the largest possible treatable tumor
sphere within the treatment zone could be quantified and
visualized for Technique A.
Standard techniques for the evaluation of the treatment
zone after focal tumor ablation are manual measurements
of perpendicular diameters on axial, coronal and/or sagit-
tal image planes [18,19]. With such a proceeding, however,
Figure 6 Summary of the most relevant Parameters for Size and Shape. A Short diameter of the treatment zone. Note: For Protocol 1 and
2, there was a trend for a smaller short diameter for Technique A, respectively. For Protocol 3, short diameter was significantly smaller for
Technique A compared with Technique B (p < 0.05). Short diameter for Technique A and Technique B was significantly different between
Protocol 1, 2 and 3 (p < 0.01 and p < 0.005, respectively). B Sphericity of the treatment zone. Note: For Protocol 1, 2 and 3, sphericity was
significantly larger for Technique A compared with Technique B, respectively (p < 0.01, p < 0.01 and p < 0.01, respectively). Sphericity for
Technique A and B was not significantly different between Protocol 1, 2 and 3. C Diameter of the largest inscribed sphere within the treatment
zone. Note: For Protocol 2, there was a trend for a smaller diameter of the largest inscribed sphere within the treatment zone for Technique A.
For Protocol 3, the diameter of the largest inscribed sphere within the treatment zone was significantly smaller for Technique A compared with
Technique B (p < 0.01). The diameter of the largest inscribed sphere within the treatment zone for Technique A and B was significantly different
between Protocol 1, 2 and 3 (p < 0.005 and p < 0.005, respectively). D Diameter of the largest possible treatable tumor sphere. Note: For Protocol
3, the diameter of the largest possible treatable tumor sphere was significantly smaller for Technique A compared with Technique B (p < 0.01).
The diameter of the largest inscribed sphere within the treatment zone for Technique A and Technique B was significantly different between
Protocol 1, 2 and 3 (p < 0.005 and p < 0.005, respectively).
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as precise as necessary. As it has been demonstrated for
liver tumors, 3d segmentation showed a better depiction
of tumor size and shape compared with conventional
image analysis [20,21]. For hepatocellular carcinoma,
Galizia et al. found that the maximum tumor diameter is
significantly different between 3d analysis and control
(32 ± 9 mm vs. 35 ± 12 mm; p < 0.001) [20]. Rothe et al.
analyzed 102 liver metastases in 45 patients, and found
significantly lower volumes for 3d analysis compared with2d analysis, with relative differences up to 41.1% [21]. For
focal tumor ablation, comparable data is very rare. In a
work published by Elhawary et al., 3d volumetric non-
rigid image registration during cryoablation could improve
the ablation procedure relating to planning, targeting and
evaluation of tumor coverage [22]. In another study, seg-
mentation with image fusion results in a more accurate
treatment control after radiofrequency ablation [23]. Ac-
cordingly, the depiction of the treatment zone after IRE
should be more exact for Technique A compared with
Table 2 Shape of the treatment zone
Circularity Sphericity
Technique A1 Technique B2 Technique A1 Technique B2
Protocol 13 0.4 ± 0.1#,* 0.6 ± 0.3#,** 1.7 ± 0.3+,*** 1.0 ± 0.2+,****
(0.3 - 0.5) (0.3 - 0.8) (1.3 - 2.0) (0.7 - 1.2)
Protocol 24 0.7 ± 0.1##,* 0.7 ± 0.2##,** 1.4 ± 0.2++,*** 0.9 ± 0.1++,****
(0.5 - 0.9) (0.4 - 0.9) (1.2 - 1.7) (0.7 - 1.0)
Protocol 35 0.5 ± 0.2###,* 0.8 ± 0.1###,** 1.6 ± 0.2+++,*** 0.9 ± 0.1+++,****
(0.3 - 0.7) (0.7 - 0.8) (1.4 - 1.9) (0.8 - 0.9)
1semi-automated software prototype for CT 3d rendering with the “Chebyshev Center Concept” implemented;
2standard CT 3d analysis;
3Protocol 1 with n = 5 IREs (three applicators, tip exposure of 20 mm, distance between pairs of applicators of 15 mm, pulse number of 90, pulse length of 90 μs,
and electric field of 1500 V/cm);
4Protocol 2 with n = 5 IREs (three applicators, tip exposure of 25 mm, distance between pairs of applicators of 20 mm, pulse number of 90, pulse length of 90 μs,
and electric field of 1500 V/cm);
5Protocol 3 with n = 5 IREs (six applicators, tip exposure of 30 mm, distance between pairs of applicators of 15 mm, pulse number of 70, pulse length of 90 μs,
and electric field of 1400 V/cm);
statistical differences between Technique A and Technique B were analyzed with the Wilcoxon signed-rank test: #p > 0.05; ##p > 0.05; ###p < 0.01; +p < 0.01;
++p < 0.01; +++p < 0.01;
statistical differences between Protocol 1, Protocol 2 and Protocol 3 were analyzed with non-parametric Kruskal-Wallis test: *p > 0.05; **p > 0.05;
***p > 0.05; ****p > 0.05.
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http://www.biomedcentral.com/1471-2342/14/2Technique B since Technique A determines automatically
the 3 perpendicular diameters after 3d segmentation with-
out being limited to analyses in the standard image planes.
Technique A allows not only assessment of the objective
size of the treatment zone (especially definition of the
short diameter, which is of paramount importance for
the oncological success) but also of the objective shape of
the treatment zone (which can be relevant to reduce
procedure-related complications such as protection ofTable 3 Diameter and position of the largest inscribed sphere
possible treatable tumor sphere
Diameter of the largest inscribed sphere within
the treatment zone (mm)
Diamet
tumor
Technique A2 Technique B3 Techniq
Protocol 14 19.6 ± 3.3#,* 19.9 ± 4.6#,** 9.6 ± 3.3
(16.6 - 24.6) (15.4 - 26.4) (6.6 - 14
Protocol 25 24.8 ± 3.4##,* 31.1 ± 10.5##,** 14.8 ± 3
(22.2 - 30.2) (17.5 - 42.1) (12.2 - 2
Protocol 36 39.0 ± 8.4###,* 53.8 ±1.1###,** 29.0 ± 8
(26.8 - 47.0) (52.4 - 54.9) (16.8 - 3
1distance between the barycenter of the treatment zone (intersection point of long
2semi-automated software prototype for CT 3d rendering with the “Chebyshev Cen
3standard CT 3d analysis;
4Protocol 1 with n = 5 IREs (three applicators, tip exposure of 20 mm, distance betw
and electric field of 1500 V/cm);
5Protocol 2 with n = 5 IREs (three applicators, tip exposure of 25 mm, distance betw
and electric field of 1500 V/cm);
6Protocol 3 with n = 5 IREs (six applicators, tip exposure of 30 mm, distance betwee
and electric field of 1400 V/cm);
statistical differences between Technique A and Technique B were analyzed with th
++ p > 0.05; +++p < 0.01;
statistical differences between Protocol 1, Protocol 2 and Protocol 3 were analyzed
****p < 0.005; *****p > 0.05;
n.a. not assessable.viable structures) [19]. Technique A is independent of
the tumor orientation with respect to the standard im-
aging planes. It is a reproducible automatic method based
on a standard mathematical analysis (principal compo-
nent analysis) of geometric shapes and also suitable for
automatic comparisons of geometric features between
imaging sessions. Our data suggest that the larger the
treatment zone is, the larger the difference regarding size
between Technique A and Technique B is. Regardingwithin the treatment zone as well as of the largest
er of the largest possible treatable
sphere (mm)
Barycenter offset1 (mm)
ue A2 Technique B3 Technique A2 Technique B3
+,*** 9.9 ± 4.6+,**** 9.1 ± 2.1***** n.a.
.6) (5.4 - 16.4) (5.4 - 10.6)
.4++,*** 21.1 ± 10.5++,**** 5.4 ± 3.6***** n.a.
0.2) (7.5 - 32.1) (1.2 - 10.1)
.4+++,*** 43.8 ±1.1+++,**** 5.9 ± 3.8***** n.a.
7.0) (42.4 - 44.9) (2.4 - 11.7)
, intermediate and short diameter) and the “Chebyshev Center”
ter Concept” implemented;
een pairs of applicators of 15 mm, pulse number of 90, pulse length of 90 μs,
een pairs of applicators of 20 mm, pulse number of 90, pulse length of 90 μs,
n pairs of applicators of 15 mm, pulse number of 70, pulse length of 90 μs,
e Wilcoxon signed-rank test: #p > 0.05; ##p > 0.05; ###p < 0.01; + p > 0.05;
with the Kruskal-Wallis test: *p < 0.005; **p < 0.005; ***p < 0.005;
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http://www.biomedcentral.com/1471-2342/14/2shape, Technique A and Technique B showed signifi-
cantly different results for all IRE protocols. Both issues
might emphasize the need for specific 3d rendering tech-
niques for focal tumor ablation if one intends an optimal
procedural outcome [24].
The spatial positioning of the multiple IRE applicators
lead to complex treatment zones regarding shape, inden-
tations and skip lesions compared with the rather pre-
dictable ellipsoid treatment zones after thermal ablation
created with one straight needle design applicator
[11,12,18]. Technique A can be used for a practicable
and precise analysis of complex treatment zones after
IRE. Per definition, the “Chebyshev Center” is the center
of the largest inscribed sphere within a three dimen-
sional body. In our study, this concept is used to define
diameter and position of the largest inscribed sphere
within the treatment zone. Technique A aligns automat-
ically the largest inscribed sphere within the treatment
zone, and calculates the barycenter offset. Due to the
fact that the diameter of the largest possible treatable
tumor sphere is smaller than the diameter of the largest
inscribed sphere within the treatment zone by twice the
safety margin, and since both spheres have the same
center (the “Chebyschev Center”), the precise location of
the largest possible treatable tumor sphere can be easily
defined. For Technique B, the diameter of the largest
possible treatable tumor sphere is determined with the
short diameter, and the barycenter offset is not assess-
able. The presented differences between Technique A
and Technique B result since only Technique A takes
into account the exact geometry of the treatment zone
including all shape irregularities (e.g. indentations). This
means, if Technique B is applied for treatment control
after focal tumor ablation, that (I) the operator can be
fooled into believing that the achieved treatment zone is
large enough to cover tumor and safety margin although
in fact the treatment zone is too small (since Technique
B overestimates the size of the treatment zone), and that
(II) the correct positioning of the treatment zone in rela-
tion to the tumor can neither be confirmed nor denied
objectively (since the barycenter offset is not quantified
and visualized). Theoretically, the downloadable MITK
freeware “Geometric evaluation of ablations“ allows
everyone to determine whether the intended safety mar-
gin was realized, or if another focal tumor ablation is ne-
cessary to destroy completely the tumor. At this point,
the authors are obliged to point out that the use of this
software is currently limited to research, and clinical de-
cisions based on this software prototype are currently
strictly forbidden. In this study, we detected differences
between Technique A and Technique B in regards of
the geometry of the treatment zone. Clinical superiority
for one technique, however, was not proven since no
clinical data were analyzed.This study has limitations. First, IRE was performed in
normal pig liver tissue, and the extent of the treatment
zone might be different in human tumor tissue (e.g.
since different cell density). CT datasets from patients
before and after IRE could be analyzed applying our ap-
proach, and the results correlated to local tumor control
during follow-up. Second, only three different IRE proto-
cols were used. Although those were clinically relevant,
alternative protocols (e.g. different number and different
spatial order of electrodes) might result in treatment
zones more difficult to determine geometrically espe-
cially applying standard CT 3d analysis. IRE protocols
are just now being optimized for different tumor sizes
and tissue characteristics (e.g. liver cirrhosis), and then
should undergo 3d analysis of the treatment zone. For
such protocols, the benefits of CT 3d rendering with the
“Chebyshev Center Concept” implemented could be
even more obvious. Third, the presented results were
collected in an acute setting. Survival studies should fur-
ther evaluate subacute and chronic effects after IRE (e.g.
imaging findings correlated to homogeneity of cell
death). Since cellular repopulation and tissue healing is
likely to occur after IRE of healthy liver tissue with
complete resolution of the treatment zone over weeks,
the clinical feasibility of our approach for acute treat-
ment control could be best evaluated for liver tumors.
Only if the tumor and safety margin is completely cov-
ered by the largest inscribed sphere within the treatment
zone on acute post-interventional CT images and the
tumor disappears during follow-up, our concept can be
regarded as clinically relevant. Fourth, the comparison
between Technique A and B is not on the same level
since an automatic technique is compared with a manual
technique. For a better comparison, an automation of
Technique B would have been required.Conclusions
Regarding size and shape of the treatment zone after
IRE, CT 3d rendering with the “Chebyshev Center Con-
cept” implemented provides significantly different results
compared with standard CT 3d analysis. Since standard
CT 3d analysis cannot assess the extent of the treatment
zone as precise as CT 3d rendering with the “Chebyshev
Center Concept” implemented (especially since overesti-
mation of the size of the treatment zone as well as the
non-assessable position of the largest possible treatable
tumor sphere within the treatment zone), the latter
might be regarded as superior. The benefits could be
used clinically to improve local tumor control due to a
more objective acute treatment control.
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